サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1493484

人工心臓の市場規模、シェア、動向分析レポート：タイプ別、治療法別、地域別、セグメント予測、2024年～2030年

Artificial Heart Market Size, Share & Trends Analysis Report By Type (Heart-lung Machine, Total Artificial Heart), By Therapy (Destination Therapy, Bridge To Transplant, Bridge To Decision), By Region, And Segment Forecasts, 2024 - 2030

出版日
ページ情報
英文 125 Pages
納期
2～10営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=148.90円
人工心臓の市場規模、シェア、動向分析レポート：タイプ別、治療法別、地域別、セグメント予測、2024年～2030年
出版日: 2024年05月22日
発行: Grand View Research
ページ情報: 英文 125 Pages
納期: 2～10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

人工心臓市場の成長と動向：

Grand View Research, Inc.の最新レポートによると、世界の人工心臓市場規模は2024年から2030年にかけてCAGR 11.3％を記録し、2030年には59億4,000万米ドルに達する見込みです。

同市場は、心血管疾患の負担増、同分野の技術進歩、高齢者人口の増加、心血管リスクの増大につながるライフスタイルの変化など、さまざまな要因によって大きな成長を遂げています。世界人口の高齢化に伴い、高齢者における心臓疾患の発生率が増加しています。この人口動向は、心不全などの治療オプションとしての人工心臓の需要に寄与しています。

CVDの世界の負担は、人口の高齢化、座りがちなライフスタイル、不健康な食生活によって増加しています。2022年5月のNCBIの記事によると、9,210万人のアメリカ人が何らかのCVDに罹患しており、2030年までに43.9％が何らかのCVDに罹患すると予測されています。同様に、英国心臓財団の2022年7月の報告書によると、2021年には男性400万人、女性360万人が心臓・循環器疾患を患っています。心臓病患者の予後改善を目指した研究への継続的な投資が、人工心臓の採用率を押し上げています。2024年1月、CARMATは人工心臓Aesonの新しいソフトウェア拡張を発表し、リアルタイムの欠陥検出と継続的な患者ケアを提供するための制御変更を可能にすることで安全性プロファイルの強化を目指しました。

人工心臓市場レポートのハイライト

  • タイプ別では、左室補助循環装置（LVAD）分野が2023年に77.40%の最大市場シェアを占める。世界の心不全有病率の上昇がLVAD市場の成長に大きく寄与しています。
  • 治療法に基づくと、目的地治療セグメントは2023年に61.8％の最大収益シェアを占め、予測期間中に11.8％の最速CAGRを示すことが期待されています。
  • 2023年には、北米が64.1%のシェアを占め、市場を独占しました。これは、同地域の先進的なヘルスケアインフラ、有利な償還政策、技術の進歩によるものです。Abbott、BiVacor、SynCardiaといった大手市場プレイヤーの存在がこの地域の市場を独占しています。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 人工心臓市場の変数、動向、範囲

  • 市場系統の見通し
    • 親市場の見通し
    • 関連/付随市場の見通し
  • 市場力学
    • 市場牽引要因分析
    • 市場抑制要因分析
  • 人工心臓市場分析ツール
    • 業界分析- ポーターのファイブフォース分析
    • PESTEL分析

第4章 人工心臓市場：タイプ推定・動向分析

  • 人工心臓市場：タイプダッシュボード
  • 人工心臓市場：タイプ変動分析
  • 人工心臓市場規模と予測および動向分析、タイプ別、2018～2030年
  • LVAD
  • 人工心肺
  • 完全人工心臓

第5章 人工心臓市場：治療法推定・動向分析

  • 人工心臓市場：治療法ダッシュボード
  • 人工心臓市場：治療法変動分析
  • 人工心臓市場規模と予測および動向分析、治療法別、2018～2030年
  • BTT
  • DT
  • BTD
  • その他

第6章 人工心臓市場：国、タイプ、治療法別の地域推定・動向分析

  • 人工心臓市場：地域ダッシュボード
  • 市場規模と予測動向分析、2018年から2030年
  • 北米
  • 欧州
  • アジア太平洋地域
  • ラテンアメリカ
  • 中東・アフリカ

第7章 競合情勢

  • 主要市場参入企業による最近の動向と影響分析
  • 企業/競合の分類
  • ベンダー情勢
    • 主要ディストリビューターおよびチャネルパートナーのリスト
    • 主要顧客
    • 主要企業の市場シェア分析、2023年
    • SynCardia Systems, LLC
    • CARMAT
    • BiVacor
    • RealHeart
    • Abbott
    • Abiomed（Johnson &Johnson Services Inc）
    • Jarvik Heart, Inc
    • LivaNova PLC
    • Getinge AB
    • Terumo
図表

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviation
  • Table 3 North America artificial heart market, by country, 2018 - 2030 (USD Million)
  • Table 4 North America artificial heart market, by type, 2018 - 2030 (USD Million)
  • Table 5 North America artificial heart market, by therapy, 2018 - 2030 (USD Million)
  • Table 6 U.S. artificial heart market, by type, 2018 - 2030 (USD Million)
  • Table 7 U.S. artificial heart market, by therapy, 2018 - 2030 (USD Million)
  • Table 8 Canada artificial heart market, by type, 2018 - 2030 (USD Million)
  • Table 9 Canada artificial heart market, by therapy , 2018 - 2030 (USD Million)
  • Table 10 Europe artificial heart market, by country, 2018 - 2030 (USD Million)
  • Table 11 Europe artificial heart market, by type, 2018 - 2030 (USD Million)
  • Table 12 Europe artificial heart market, by therapy , 2018 - 2030 (USD Million)
  • Table 13 UK artificial heart market, by type, 2018 - 2030 (USD Million)
  • Table 14 UK artificial heart market, by therapy , 2018 - 2030 (USD Million)
  • Table 15 Germany artificial heart market, by type, 2018 - 2030 (USD Million)
  • Table 16 Germany artificial heart market, by therapy , 2018 - 2030 (USD Million)
  • Table 17 France artificial heart market, by type, 2018 - 2030 (USD Million)
  • Table 18 France artificial heart market, by therapy , 2018 - 2030 (USD Million)
  • Table 19 Italy artificial heart market, by type, 2018 - 2030 (USD Million)
  • Table 20 Italy artificial heart market, by therapy , 2018 - 2030 (USD Million)
  • Table 21 Spain artificial heart market, by type, 2018 - 2030 (USD Million)
  • Table 22 Spain artificial heart market, by therapy , 2018 - 2030 (USD Million)
  • Table 23 Denmark artificial heart market, by type, 2018 - 2030 (USD Million)
  • Table 24 Denmark artificial heart market, by therapy , 2018 - 2030 (USD Million)
  • Table 25 Sweden artificial heart market, by type, 2018 - 2030 (USD Million)
  • Table 26 Sweden artificial heart market, by therapy , 2018 - 2030 (USD Million)
  • Table 27 Norway artificial heart market, by type, 2018 - 2030 (USD Million)
  • Table 28 Norway artificial heart market, by therapy , 2018 - 2030 (USD Million)
  • Table 29 Asia Pacific artificial heart market, by country, 2018 - 2030 (USD Million)
  • Table 30 Asia Pacific artificial heart market, by type, 2018 - 2030 (USD Million)
  • Table 31 Asia Pacific artificial heart market, by therapy , 2018 - 2030 (USD Million)
  • Table 32 Japan artificial heart market, by type, 2018 - 2030 (USD Million)
  • Table 33 Japan artificial heart market, by therapy , 2018 - 2030 (USD Million)
  • Table 34 China artificial heart market, by type, 2018 - 2030 (USD Million)
  • Table 35 China artificial heart market, by therapy , 2018 - 2030 (USD Million)
  • Table 36 India artificial heart market, by type, 2018 - 2030 (USD Million)
  • Table 37 India artificial heart market, by therapy , 2018 - 2030 (USD Million)
  • Table 38 Australia artificial heart market, by type, 2018 - 2030 (USD Million)
  • Table 39 Australia artificial heart market, by therapy , 2018 - 2030 (USD Million)
  • Table 40 South Korea artificial heart market, by type, 2018 - 2030 (USD Million)
  • Table 41 South Korea artificial heart market, by therapy , 2018 - 2030 (USD Million)
  • Table 42 Thailand artificial heart market, by type, 2018 - 2030 (USD Million)
  • Table 43 Thailand artificial heart market, by therapy , 2018 - 2030 (USD Million)
  • Table 44 Latin America artificial heart market, by country, 2018 - 2030 (USD Million)
  • Table 45 Latin America artificial heart market, by type, 2018 - 2030 (USD Million)
  • Table 46 Latin America artificial heart market, by therapy , 2018 - 2030 (USD Million)
  • Table 47 Brazil artificial heart market, by type, 2018 - 2030 (USD Million)
  • Table 48 Brazil artificial heart market, by therapy , 2018 - 2030 (USD Million)
  • Table 49 Mexico artificial heart market, by type, 2018 - 2030 (USD Million)
  • Table 50 Mexico artificial heart market, by therapy , 2018 - 2030 (USD Million)
  • Table 51 Argentina artificial heart market, by type, 2018 - 2030 (USD Million)
  • Table 52 Argentina artificial heart market, by therapy , 2018 - 2030 (USD Million)
  • Table 53 MEA artificial heart market, by country, 2018 - 2030 (USD Million)
  • Table 54 MEA artificial heart market, by type, 2018 - 2030 (USD Million)
  • Table 55 MEA artificial heart market, by therapy, 2018 - 2030 (USD Million)
  • Table 56 South Africa artificial heart market, by type, 2018 - 2030 (USD Million)
  • Table 57 South Africa artificial heart market, by therapy , 2018 - 2030 (USD Million)
  • Table 58 Saudi Arabia artificial heart market, by type, 2018 - 2030 (USD Million)
  • Table 59 Saudi Arabia artificial heart market, by therapy, 2018 - 2030 (USD Million)
  • Table 60 UAE artificial heart market, by type, 2018 - 2030 (USD Million)
  • Table 61 UAE artificial heart market, by therapy , 2018 - 2030 (USD Million)
  • Table 62 Kuwait artificial heart market, by type, 2018 - 2030 (USD Million)
  • Table 63 Kuwait artificial heart market, by therapy , 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information procurement
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 QFD modelling for market share assessment
  • Fig. 6 Market formulation & validation
  • Fig. 7 Market outlook
  • Fig. 8 Artificial heart market segmentation
  • Fig. 9 Penetration & growth prospect mapping
  • Fig. 10 Market trends & outlook
  • Fig. 11 Market driver relevance analysis (Current & future impact)
  • Fig. 12 Market restraint relevance analysis (Current & future impact)
  • Fig. 13 Artificial heart type market share analysis, 2023 & 2030
  • Fig. 14 Artificial heart type market: Segment dashboard
  • Fig. 15 LVADs market estimates and forecast, 2018 - 2030
  • Fig. 16 Heart-lung machine market estimates and forecast, 2018 - 2030
  • Fig. 17 Total artificial heart market estimates and forecast, 2018 - 2030
  • Fig. 18 Artificial heart therapy market share analysis, 2023 & 2030
  • Fig. 19 Artificial heart therapy market: Segment dashboard
  • Fig. 20 Bridge to transplant market estimates and forecasts, 2018 - 2030
  • Fig. 21 Destination therapy market estimates and forecasts,2018 - 2030
  • Fig. 22 Bridge to decision market estimates and forecasts, 2018 - 2030
  • Fig. 23 Others market estimates and forecasts, 2018 - 2030
  • Fig. 24 Artificial heart regional market share analysis, 2023 & 2030
  • Fig. 25 Artificial heart regional market: Segment dashboard
  • Fig. 26 North America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 27 U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 28 Canada market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 29 Europe market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 30 UK market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 31 Germany market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 32 France market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 33 Italy market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 34 Spain market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 35 Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 36 Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 37 Norway market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 38 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 39 Japan market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 40 China market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 41 India market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 42 Australia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 43 South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 44 Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 45 Latin America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 46 Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 48 Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 Middle East and Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 50 South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 52 UAE market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 53 Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 54 Company market position analysis
目次
Product Code: GVR-4-68040-275-4

Artificial Heart Market Growth & Trends:

The global artificial heart market size is expected to reach USD 5.94 billion by 2030, registering a CAGR of 11.3% from 2024 to 2030, according to a new report by Grand View Research, Inc. The market is experiencing significant growth, driven by various factors such as the increasing burden of cardiovascular diseases, technological advancements in the field, a growing geriatric population, and lifestyle changes leading to higher cardiovascular risks. As the global population ages, there is an increased incidence of cardiac issues among older individuals. This demographic trend contributes to the demand for artificial hearts as a treatment option for heart failure and other conditions.

The global burden of CVDs is increasing, driven by the aging population, sedentary lifestyles, and unhealthy diets. According to an article by NCBI in May 2022, 92.1 million Americans are affected by some form of CVD, and it is predicted that 43.9% will have some type of CVD by 2030. Similarly, according to the British Heart Foundation's July 2022 report, 4 million men and 3.6 million women lived with heart and circulatory diseases in 2021. Continued investment in research aimed at improving cardiac patient outcomes drives adoption rates for artificial hearts. In January 2024, CARMAT introduced a new software enhancement for its artificial heart Aeson, aiming to enhance its safety profile by enabling real-time defect detection and modifying control to provide continuous patient care.

Artificial Heart Market Report Highlights:

  • Based on type, the left ventricular assist device (LVAD) segment held the largest market share of 77.40% in 2023. The rising prevalence of heart failure globally has contributed significantly to the growth of the LVAD market
  • Based on therapy, the destination therapy segment accounted for the largest revenue share of 61.8% in 2023 and is expected to witness the fastest CAGR of 11.8% during the forecast period. owing to the increasing prevalence of advanced heart failure patients who are ineligible for heart transplantation or other therapies
  • In 2023, North America dominated the market with a share of 64.1% due to the advanced healthcare infrastructure, favorable reimbursement policies, and technological advancements in the region. The presence of major market players such as Abbott, BiVacor and SynCardia dominates the market in this region

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Type
    • 1.2.2. Therapy
    • 1.2.3. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
  • 1.8. Commodity price analysis (Model 1)
  • 1.9. Approach 1: Commodity flow approach
  • 1.10. List of Secondary Sources
  • 1.11. List of Primary Sources
  • 1.12. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Type outlook
    • 2.2.2. Therapy outlook
    • 2.2.3. Regional Outlook
  • 2.3. Competitive Insights

Chapter 3. Artificial Heart Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver Analysis
    • 3.2.2. Market restraint analysis
  • 3.3. Artificial Heart Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape

Chapter 4. Artificial Heart Market: Type Estimates & Trend Analysis

  • 4.1. Artificial Heart Market: Type Dashboard
  • 4.2. Artificial Heart Market: Type Movement Analysis
  • 4.3. Artificial Heart Market Size & Forecasts and Trend Analysis, by Type, 2018 to 2030 (USD Million)
  • 4.4. LVADs
    • 4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.5. Heart-lung Machine
    • 4.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.6. Total Artificial Heart
    • 4.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Artificial Heart Market: Therapy Estimates & Trend Analysis

  • 5.1. Artificial Heart Market: Therapy Dashboard
  • 5.2. Artificial Heart Market: Therapy Movement Analysis
  • 5.3. Artificial Heart Market Size & Forecasts and Trend Analysis, by Therapy, 2018 to 2030 (USD Million)
  • 5.4. Bridge to transplant
    • 5.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.5. Destination Therapy
    • 5.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.6. Bridge to decision
    • 5.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.7. Others
    • 5.7.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Artificial Heart Market: Regional Estimates & Trend Analysis by Country, Type & Therapy

  • 6.1. Artificial Heart Market: Regional Dashboard
  • 6.2. Market Size & Forecasts Trend Analysis, 2018 to 2030
  • 6.3. North America
    • 6.3.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 6.3.2. U.S.
      • 6.3.2.1. Key country dynamics
      • 6.3.2.2. Regulatory framework/ reimbursement structure
      • 6.3.2.3. Competitive scenario
      • 6.3.2.4. U.S. market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.3.3. Canada
      • 6.3.3.1. Key country dynamics
      • 6.3.3.2. Regulatory framework/ reimbursement structure
      • 6.3.3.3. Competitive scenario
      • 6.3.3.4. Canada market estimates and forecast, 2018 - 2030 (USD Million)
  • 6.4. Europe
    • 6.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 6.4.2. UK
      • 6.4.2.1. Key country dynamics
      • 6.4.2.2. Regulatory framework/ reimbursement structure
      • 6.4.2.3. Competitive scenario
      • 6.4.2.4. UK market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.4.3. Germany
      • 6.4.3.1. Key country dynamics
      • 6.4.3.2. Regulatory framework/ reimbursement structure
      • 6.4.3.3. Competitive scenario
      • 6.4.3.4. Germany market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.4.4. France
      • 6.4.4.1. Key country dynamics
      • 6.4.4.2. Regulatory framework/ reimbursement structure
      • 6.4.4.3. Competitive scenario
      • 6.4.4.4. France market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.4.5. Italy
      • 6.4.5.1. Key country dynamics
      • 6.4.5.2. Regulatory framework/ reimbursement structure
      • 6.4.5.3. Competitive scenario
      • 6.4.5.4. Italy market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.4.6. Spain
      • 6.4.6.1. Key country dynamics
      • 6.4.6.2. Regulatory framework/ reimbursement structure
      • 6.4.6.3. Competitive scenario
      • 6.4.6.4. Spain market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.4.7. Sweden
      • 6.4.7.1. Key country dynamics
      • 6.4.7.2. Regulatory framework/ reimbursement structure
      • 6.4.7.3. Competitive scenario
      • 6.4.7.4. Sweden market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.4.8. Norway
      • 6.4.8.1. Key country dynamics
      • 6.4.8.2. Regulatory framework/ reimbursement structure
      • 6.4.8.3. Competitive scenario
      • 6.4.8.4. Norway market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.4.9. Denmark
      • 6.4.9.1. Key country dynamics
      • 6.4.9.2. Regulatory framework/ reimbursement structure
      • 6.4.9.3. Competitive scenario
      • 6.4.9.4. Denmark market estimates and forecast, 2018 - 2030 (USD Million)
  • 6.5. Asia Pacific
    • 6.5.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 6.5.2. China
      • 6.5.2.1. Key country dynamics
      • 6.5.2.2. Regulatory framework/ reimbursement structure
      • 6.5.2.3. Competitive scenario
      • 6.5.2.4. China market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.5.3. Japan
      • 6.5.3.1. Key country dynamics
      • 6.5.3.2. Regulatory framework/ reimbursement structure
      • 6.5.3.3. Competitive scenario
      • 6.5.3.4. Japan market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.5.4. India
      • 6.5.4.1. Key country dynamics
      • 6.5.4.2. Regulatory framework/ reimbursement structure
      • 6.5.4.3. Competitive scenario
      • 6.5.4.4. India market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.5.5. Australia
      • 6.5.5.1. Key country dynamics
      • 6.5.5.2. Regulatory framework/ reimbursement structure
      • 6.5.5.3. Competitive scenario
      • 6.5.5.4. Australia market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.5.6. Thailand
      • 6.5.6.1. Key country dynamics
      • 6.5.6.2. Regulatory framework/ reimbursement structure
      • 6.5.6.3. Competitive scenario
      • 6.5.6.4. Thailand market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.5.7. South Korea
      • 6.5.7.1. Key country dynamics
      • 6.5.7.2. Regulatory framework/ reimbursement structure
      • 6.5.7.3. Competitive scenario
      • 6.5.7.4. South Korea market estimates and forecast, 2018 - 2030 (USD Million)
  • 6.6. Latin America
    • 6.6.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 6.6.2. Brazil
      • 6.6.2.1. Key country dynamics
      • 6.6.2.2. Regulatory framework/ reimbursement structure
      • 6.6.2.3. Competitive scenario
      • 6.6.2.4. Brazil market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.6.3. Mexico
      • 6.6.3.1. Key country dynamics
      • 6.6.3.2. Regulatory framework/ reimbursement structure
      • 6.6.3.3. Competitive scenario
      • 6.6.3.4. Mexico market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.6.4. Argentina
      • 6.6.4.1. Key country dynamics
      • 6.6.4.2. Regulatory framework/ reimbursement structure
      • 6.6.4.3. Competitive scenario
      • 6.6.4.4. Argentina market estimates and forecast, 2018 - 2030 (USD Million)
  • 6.7. MEA
    • 6.7.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 6.7.2. Saudi Arabia
      • 6.7.2.1. Key country dynamics
      • 6.7.2.2. Regulatory framework/ reimbursement structure
      • 6.7.2.3. Competitive scenario
      • 6.7.2.4. Saudi Arabia market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.7.3. South Africa
      • 6.7.3.1. Key country dynamics
      • 6.7.3.2. Regulatory framework/ reimbursement structure
      • 6.7.3.3. Competitive scenario
      • 6.7.3.4. South Africa market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.7.4. UAE
      • 6.7.4.1. Key country dynamics
      • 6.7.4.2. Regulatory framework/ reimbursement structure
      • 6.7.4.3. Competitive scenario
      • 6.7.4.4. UAE market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.7.5. Kuwait
      • 6.7.5.1. Key country dynamics
      • 6.7.5.2. Regulatory framework/ reimbursement structure
      • 6.7.5.3. Competitive scenario
      • 6.7.5.4. Kuwait market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 7.2. Company/Competition Categorization
  • 7.3. Vendor Landscape
    • 7.3.1. List of key distributors and channel partners
    • 7.3.2. Key customers
    • 7.3.3. Key company market share analysis, 2023
    • 7.3.4. SynCardia Systems, LLC
      • 7.3.4.1. Company overview
      • 7.3.4.2. Financial performance
      • 7.3.4.3. Type benchmarking
      • 7.3.4.4. Strategic initiatives
    • 7.3.5. CARMAT
      • 7.3.5.1. Company overview
      • 7.3.5.2. Financial performance
      • 7.3.5.3. Type benchmarking
      • 7.3.5.4. Strategic initiatives
    • 7.3.6. BiVacor
      • 7.3.6.1. Company overview
      • 7.3.6.2. Financial performance
      • 7.3.6.3. Type benchmarking
      • 7.3.6.4. Strategic initiatives
    • 7.3.7. RealHeart
      • 7.3.7.1. Company overview
      • 7.3.7.2. Financial performance
      • 7.3.7.3. Type benchmarking
      • 7.3.7.4. Strategic initiatives
    • 7.3.8. Abbott
      • 7.3.8.1. Company overview
      • 7.3.8.2. Financial performance
      • 7.3.8.3. Type benchmarking
      • 7.3.8.4. Strategic initiatives
    • 7.3.9. Abiomed (Johnson & Johnson Services Inc)
      • 7.3.9.1. Company overview
      • 7.3.9.2. Financial performance
      • 7.3.9.3. Type benchmarking
      • 7.3.9.4. Strategic initiatives
    • 7.3.10. Jarvik Heart, Inc
      • 7.3.10.1. Company overview
      • 7.3.10.2. Financial performance
      • 7.3.10.3. Type benchmarking
      • 7.3.10.4. Strategic initiatives
    • 7.3.11. LivaNova PLC
      • 7.3.11.1. Company overview
      • 7.3.11.2. Financial performance
      • 7.3.11.3. Type benchmarking
      • 7.3.11.4. Strategic initiatives
    • 7.3.12. Getinge AB
      • 7.3.12.1. Company overview
      • 7.3.12.2. Financial performance
      • 7.3.12.3. Type benchmarking
      • 7.3.12.4. Strategic initiatives
    • 7.3.13. Terumo
      • 7.3.13.1. Company overview
      • 7.3.13.2. Financial performance
      • 7.3.13.3. Type benchmarking
      • 7.3.13.4. Strategic initiatives